Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

BioAtla (BCAB) Revenue (2020 - 2024)

BioAtla (BCAB) has 2 years of Revenue data on record, last reported at $250000.0 in Q2 2021.

  • For Q2 2021, Revenue rose 31.58% year-over-year to $250000.0; the TTM value through Mar 2022 reached $250000.0, down 26.47%, while the annual FY2024 figure was $11.0 million, N/A changed from the prior year.
  • Revenue reached $250000.0 in Q2 2021 per BCAB's latest filing, up from $150000.0 in the prior quarter.
  • Across five years, Revenue topped out at $250000.0 in Q2 2021 and bottomed at $89000.0 in Q1 2020.